MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze SWKH →
    • FindStock Picks / Stock Screener
    • Value · SWKHIntrinsic Value Calculator
    • Invest · SWKHInvestment Case
    • Hold · SWKH5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
SWKH stock logo

SWKH

SWK Holdings Corporation

$15.9
0
 (-4.96%)
Exchange:  NASDAQ
Market Cap:  192.326M
Shares Outstanding:  12.852M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Financial ServicesView sector performance
Industry:  Asset ManagementView industry performance
   
CEO:  Jody. D Staggs
Full Time Employees:  24
Address: 
14755 Preston Road
Dallas
TX
75254
US
Website:  https://www.swkhold.com
SWK Holdings Corporation (SWKH) operates as a specialized financial institution, primarily concentrating its efforts within the healthcare sector. The company’s operations are distinctly divided into two core segments: Finance Receivables and Pharmaceutical Development. Within its finance division, SWK offers bespoke funding solutions tailored to a diverse array of life science enterprises. These include companies spanning biotechnology, medical devices, diagnostic tools, animal health, and pharmaceuticals, alongside various institutions and individual innovators. Furthermore, the company extends non-discretionary investment advisory services, managing separate accounts for institutional clients keen on investing in the life science finance domain. Its Pharmaceutical Development segment involves the creation, formulation, production, and licensing of pharmaceutical products, leveraging its proprietary Peptelligence platform. A key strategic objective here is to license its internally developed product pipeline to external partners, aiming to generate innovative formulations through its unique technology, ultimately designed to benefit patients and their caregivers. Founded in 1996, the company underwent a name change from Kana Software, Inc. to SWK Holdings Corporation in December 2009. Its corporate headquarters are situated in Dallas, Texas.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
SWSWKH logoSWKHSWK Holdings Corporation192.3M—7.6-2.9%
PNPNNT logoPNNTPennantPark Investment Corporation198.5M20.15.61.9%
SCSCM logoSCMStellus Capital Investment Corporation201.1M7.06.74.0%
TPTPVG logoTPVGTriplePoint Venture Growth BDC Corp.179.9M4.74.96.9%
WHWHG logoWHGWestwood Holdings Group, Inc.176.7M20.3—3.7%
LILIEN logoLIENChicago Atlantic BDC, Inc.208.6M6.76.10.7%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/16 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue37,76044,98741,457
Gross Profit34,32442,7840
EBITDA19,37224,87124,953
Operating Income14,65011,58620,275
Net Income15,88713,488-2,533

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets334,254332,235272,422
Total Liabilities53,93943,54537,324
Total Stockholders Equity280,315288,690235,098
Total Debt43,13137,64532,110
Cash and Cash Equivalents4,5035,92742,763

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow14,88823,04927,286
Capital Expenditure-496-138-512
Free Cash Flow14,39222,91126,774
Net Income15,88713,488-2,533
Net Change in Cash-92069136,836

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2026Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)38,174.693Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)38,174.693Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)38,174.693Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)36,487.202Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)36,487.202Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)36,487.202Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)25,521.959Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)25,521.959Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)25,521.959Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)11,223.735Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)11,223.735Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)11,223.735Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)2.100Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)2.100Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)2.100Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)1Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
6.65
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
-27.41
?Enterprise Value
 (TTM)
: 
181.673M  ?EV/FCF
 (TTM)
: 
9.77
?Dividend Yield
 (TTM)
: 
25.16%  ?Payout Ratio
 (TTM)
: 
-693.98%
?ROE
 (TTM)
: 
-2.88%  ?ROIC
 (TTM)
: 
-2.94%
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.14
?P/B
 (TTM)
: 
0.82  ?Current Ratio
 (TTM)
: 
9.41

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
7.57Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates SWKH intrinsic value between $13.59 – $24.19 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate SWKH Intrinsic Value

Common questions about SWKH valuation

Is SWK Holdings Corporation (SWKH) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for SWK Holdings Corporation (SWKH) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is SWKH a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether SWKH trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is SWKH’s P/E ratio?

You can see SWKH’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for SWKH?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is SWKH a good long-term investment?

Whether SWKH fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for SWK Holdings Corporation

  • SWK Holdings Corporation intrinsic value calculatorEstimate what the business is worth
  • SWK Holdings Corporation 5-year outlookWhat has to go right, and what could go wrong
SWKH

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-4.96
MarketSnap

Trading Metrics:

Open: —   Previous Close: —
Day Low: —   Day High: —
Year Low:    Year High: 
Price Avg 50:    Price Avg 200: 
Volume:    Average Volume: 

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

SWK vs. LECO: Which Stock Is the Better Value Option?
Will Stanley Black & Decker (SWK) Beat Estimates Again in Its Next Earnings Report?
Stanley Black & Decker, Inc. (SWK) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze SWKH →
    • FindStock Picks / Stock Screener
    • Value · SWKHIntrinsic Value Calculator
    • Invest · SWKHInvestment Case
    • Hold · SWKH5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read